Xenon Pharmaceuticals Stock Technical Analysis
| XENE Stock | USD 39.10 1.45 3.85% |
As of the 26th of February, Xenon Pharmaceuticals maintains the Standard Deviation of 2.04, mean deviation of 1.55, and Market Risk Adjusted Performance of (0.05). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xenon Pharmaceuticals, as well as the relationship between them. Please check out Xenon Pharmaceuticals market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Xenon Pharmaceuticals is priced fairly, providing market reflects its latest price of 39.1 per share. Given that Xenon Pharmaceuticals has information ratio of (0.01), we strongly advise you to confirm Xenon Pharmaceuticals's prevalent market performance to make sure the company can sustain itself at a future point.
Xenon Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Xenon, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to XenonXenon |
Xenon Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 57.67 | Strong Buy | 16 | Odds |
Most Xenon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Xenon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Xenon Pharmaceuticals, talking to its executives and customers, or listening to Xenon conference calls.
Xenon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Xenon Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Xenon Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Xenon Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Xenon Pharmaceuticals. You can use it to identify possible trend reversals for Xenon Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Xenon Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Xenon Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Xenon Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.05 , which may suggest that Xenon Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 90.5, which is the sum of squared deviations for the predicted Xenon Pharmaceuticals price change compared to its average price change.About Xenon Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Xenon Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Xenon Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Xenon Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Xenon Pharmaceuticals. By analyzing Xenon Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Xenon Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Xenon Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2024 | 2025 (projected) | Days Sales Outstanding | 38.15 | 34.33 | 64.67 | PTB Ratio | 3.31 | 3.82 | 3.18 |
Xenon Pharmaceuticals February 26, 2025 Technical Indicators
Most technical analysis of Xenon help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Xenon from various momentum indicators to cycle indicators. When you analyze Xenon charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0044 | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 1.55 | |||
| Coefficient Of Variation | (37,532) | |||
| Standard Deviation | 2.04 | |||
| Variance | 4.18 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 11.58 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 3.15 | |||
| Skewness | (0.99) | |||
| Kurtosis | 2.87 |
Xenon Pharmaceuticals February 26, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Xenon stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 29,428 | ||
| Daily Balance Of Power | 0.60 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 38.78 | ||
| Day Typical Price | 38.89 | ||
| Price Action Indicator | 1.04 |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |